Valuation check: ARGX.BR's profit margin is 37.4%, above the Healthcare sector average of 21.75%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
argenx SE (ARGX.BR) currently reports a profit margin of 37.4% as of September 2026. That compares with 30.02% in the prior-year period — up 24.6% year over year. That is above the Healthcare sector average of 21.75%. Use the charts on this page to explore argenx SE's profit margin history and peer comparisons.
argenx SE's profit margin increased from 30.02% to 37.4% — a 24.6% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
argenx SE's profit margin of 37.4% is higher than the Healthcare sector average of 21.75%. That is roughly 72.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but argenx SE's current 37.4% should be judged against Healthcare norms (sector average: 21.75%) and against ARGX.BR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 37.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.75%. From there, open related valuation or income-statement pages for argenx SE, and consider following ARGX.BR for alerts when major investors trade the stock.